Department of Medical Oncology, National Center for Tumor Diseases, Programme for Ethics and Patient-Oriented Care in Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Department of Internal Medicine III, University Hospital Großhadern; Ludwig-Maximilian University, Munich, Germany.
Oncologist. 2018 Feb;23(2):256-262. doi: 10.1634/theoncologist.2017-0094. Epub 2017 Nov 13.
Empirical research demonstrates that there is a tendency to administer tumor-directed therapy to patients with advanced cancer close to death, especially if they are young. The aim of this qualitative study was to understand oncologists' treatment decisions and oncology nurses' perception of these decisions in young adult patients and to investigate the extent to which young age was a factor in cancer treatment decisions.
We conducted 29 face-to-face interviews with oncologists and oncology nurses at the Department of Hematology and Oncology at the University Hospital in Munich, Germany. The interviews were analyzed according to the grounded theory approach.
Oncologists and nurses reported that decisions about limiting cancer treatment with young adult patients are the most challenging and stressful in clinical practice. Apart from using young age as a proxy for patient's medical fitness, oncologists' decisions in favor of more aggressive treatment of younger patients were mainly guided by ethical reasons such as patient preferences and the perceptions of injustice associated with dying at a young age, as well as by psychological reasons, such as identification and emotional entanglement.
"Struggling" together with the patient against the injustice of dying young for a longer lifetime is an important factor driving aggressive treatment in young adult patients. However, oncologists might run a risk of neglecting other ethical aspects, such as a principle of nonmaleficence, that might even result in life-shortening adverse events.
This study identifies two ethical and one psychological reasons for patients' overtreatment: 1) patients' preference for further treatment; 2) oncologists' perception of un-fairness of dying young; and 3) identification and emotional entanglement with patient. These findings emphasize the need for oncologists' awareness of the reasons guiding their treatment decisions - a sole focus on patients' preferences and on the fighting against the unfairness of dying young might lead to neglecting obligations of non-maleficence. Self-reflection, the balance of empathy and professional distance as well as timely end of life discussions and involvement of psycho-oncologists are needed in the care of young cancer patients.
实证研究表明,在接近死亡的晚期癌症患者中,特别是在年轻患者中,存在给予肿瘤定向治疗的趋势。本定性研究旨在了解肿瘤医生在年轻成年患者中的治疗决策以及肿瘤护士对这些决策的看法,并探讨年轻年龄在癌症治疗决策中的影响程度。
我们在德国慕尼黑大学医院血液学和肿瘤学系对肿瘤医生和肿瘤护士进行了 29 次面对面访谈。根据扎根理论方法对访谈进行了分析。
肿瘤医生和护士报告说,与年轻成年患者就限制癌症治疗进行的决策是临床实践中最具挑战性和压力的。除了将年轻年龄用作患者医疗健康的替代指标外,肿瘤医生倾向于对年轻患者进行更积极治疗的决策主要是基于伦理原因,如患者偏好以及与年轻时死亡相关的不公平感,以及心理原因,如认同和情感纠葛。
“与患者一起为延长寿命而抗争,反对年轻时的不公正死亡”是推动年轻成年患者积极治疗的重要因素。然而,肿瘤医生可能会忽略其他伦理方面,例如不伤害原则,这甚至可能导致缩短生命的不良事件。
本研究确定了患者过度治疗的两个伦理和一个心理原因:1)患者对进一步治疗的偏好;2)肿瘤医生对年轻时死亡不公平的看法;3)与患者的认同和情感纠葛。这些发现强调了肿瘤医生需要意识到指导其治疗决策的原因——仅仅关注患者的偏好以及与年轻时死亡的不公平作斗争,可能会导致忽视不伤害的义务。在年轻癌症患者的护理中,需要肿瘤医生的自我反思、同理心和专业距离的平衡,以及及时进行临终讨论并让心理肿瘤医生参与。